JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
LYEL Financials - Lyell Immunopharma Income & Cash Flow | Ledgeburg
LYEL - Lyell Immunopharma, Inc.
USD | NASDAQ | Healthcare
Summary
Summary LYEL Stock
Financials
Financials LYEL Stock
Loading...
Loading...
Income Statement
Income Statement LYEL Stock
Balance Sheet
Balance Sheet LYEL Stock
Cash Flow Statement
Cash Flow Statement LYEL Stock
Loading...
Loading...
Home
Stocks
Lyell Immunopharma, Inc. (LYEL)
Financials
Financials of LYEL
Loading...
Loading...
Loading...
Loading...
Revenue
$36K
Operating Income
$-269.404M
Net Income
$-274.448M
Share Count (Basic)
17.093M
Operating Cash Flow
$-150.024M
Free Cash Flow
$-150.804M
Cash And Short-Term Equivalents
$247.22M
Total Debt
N/A
Annual
Quarterly
Revenue $USD
0
20M
40M
60M
80M
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue $USD
0
5K
10K
15K
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Annual
Quarterly
Net Income $USD
-350M
-300M
-250M
-200M
Annual
Quarterly
Margins
Gross
Operating
Net
-800000%
-600000%
-400000%
-200000%
0%
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-150M
-100M
-50M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-2000000%
-1500000%
-1000000%
-500000%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26